Quantcast

Latest StemCells Inc. Stories

2014-05-16 12:27:27

Editor Note: For more information about this release, please scroll to bottom. LONDON, May 16, 2014 /PRNewswire/ -- The US markets saw a negative sentiment on Thursday, May 15, 2014, with the NASDAQ Composite closing at 4,069.29, down 0.76%, the Dow Jones Industrial Average ending the session at 16,446.81, down 1.01% and the S&P 500 finishing 0.94% lower at 1,870.85. The losses were broad based as nine out of ten sectors finished on a lower note. A number of stocks saw...

2014-03-24 12:25:44

Editor Note: For more information about this release, please scroll to bottom. LONDON, March 24, 2014 /PRNewswire/ -- On Friday, March 20, 2014, the NASDAQ Composite ended at 4,276.79, down 0.98%, the Dow Jones Industrial Average fell by 0.17% to close at 16,302.77, and the S&P 500 finished at 1,866.52, down 0.29%. Four out of ten sectors ended the session in negative. During the session gains in the Utilities, Materials and Energy sectors positively impacted the broader...

2013-06-25 23:25:04

MarketResearch.com announces the addition of a new market research report in Biotechnology to their product offering:Regenerative Medicine Markets; http://www.marketresearch.com/land/product.asp?productid=7458272&progid=85536 Rockville, MD (PRWEB) June 25, 2013 Regenerative Medicine Markets TriMarkPublications.com cites in its newly published “Regenerative Medicine Markets” report that the regenerative medicine market will catapult to over $35 billion by 2019. Regenerative...

New Hope For Children With Fatal Brain Diseases Offered By Human Neural Stem Cells Study
2012-10-10 15:41:20

New findings demonstrate potential to treat a wide variety of disorders that affect myelin Physician-scientists at Oregon Health & Science University Doernbecher Children's Hospital have demonstrated for the first time that banked human neural stem cells – HuCNS-SCs, a proprietary product of StemCells Inc. – can survive and make functional myelin in mice with severe symptoms of myelin loss. Myelin is the critical fatty insulation, or sheath, surrounding new nerve fibers and...

2012-02-17 11:00:00

In a month, where the Pennsylvania Association for the Blind is creating awareness on Age-Related Macular Degeneration (AMD,) drug researcher StemCells Inc. (STEM) received authorization from the U.S. Food and Drug Administration (FDA) to start a clinical trial on the potential treatment for dry age-related macular degeneration. Mechanicsburg, Pennsylvania (PRWEB) February 17, 2012 In a month, where the Pennsylvania Association for the Blind is creating awareness on Age-Related Macular...

959084475c111136ecc44a6aa33ef5811
2010-11-16 06:35:00

StemCells Inc. has filed for Swiss regulatory approval for clinical trials of its nerve stem cells in patients with spinal cord injuries, the company said. The stem cell research and development firm expects to enroll about a dozen patients whose injuries are as much as 12 months old. StemCells CEO Martin McGlynn said in a phone interview with Reuters that until now, the main focus has been on the "acute spinal cord injury phase." Although that is an important area that needs addressing,...

2009-09-03 15:32:36

A new study finds substantial improvement in a mouse model of a rare, hereditary neurodegenerative disease after transplantation of normal human neural stem cells. The research findings, published by Cell Press in the September 4th issue of the journal Cell Stem Cell, show that the transplanted cells provided a critical enzyme that was missing in the brains of the experimental mice and represent an important step toward what may be a successful therapeutic approach for a currently untreatable...

2008-11-14 09:00:34

StemCells, Inc. (Nasdaq:STEM) announced today that results pertaining to the Company's research programs in retinal degeneration as well as spinal cord injury will be presented at the Society for Neuroscience Annual Meeting scheduled for November 15-19, 2008 in Washington, DC. The Society for Neuroscience is the world's largest organization devoted to advancing understanding of the brain and nervous system. Its annual meeting is one of the leading forums for neuroscientists from around the...

2008-11-12 09:00:45

StemCells, Inc. (NASDAQ:STEM) announced today that it has entered into agreements to raise approximately $20 million in gross proceeds through the sale of approximately 13.8 million shares of its common stock to selected institutional investors at a price of $1.45 per share. The investors will also receive warrants to purchase approximately 10.3 million shares of common stock at an exercise price of $2.30 per share. The shares and warrants are being offered as a registered direct offering...

2008-10-30 09:00:41

StemCells, Inc. (NASDAQ:STEM) reported today that its proprietary HuCNS-SC(R) product candidate (purified human neural stem cells), when transplanted into a well-established animal model, can protect the retina from progressive degeneration. Retinal degeneration leads to loss of vision in diseases such as age-related macular degeneration and retinitis pigmentosa. This promising study was conducted by Dr. Raymond Lund, a researcher and professor at the Casey Eye Institute at Oregon Health...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'